George G. Abdelsayed, MD

Gastroenterology in New Brunswick, NJ

125 Paterson St, New Brunswick, NJ 08901 · Rutgers Health-Rwj Scleroderma Program
NPI 1144298613 Accepts Medicare assignment 43 years since graduation Public record — not managed by the clinician

About Dr. George Abdelsayed

Dr. George Abdelsayed is a physician specializing in gastroenterology practicing in New Brunswick, NJ, a graduate of New York Medical College (1983). Records list 2 practice addresses. Affiliated with Bayonne University Hospital, Hoboken University Hospital, Robert Wood Johnson University Hospital. Treated 215 Medicare patients in 2024.

SpecialtyGastroenterologyOther gastroenterology doctors in New Brunswick
CredentialsMD
EducationNew York Medical College, 1983CMS Doctors and Clinicians
GenderMale
NPI number1144298613National Provider Identifier (CMS NPPES), issued March 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Where Dr. George Abdelsayed practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. George Abdelsayed's specialties and state licenses

Specialty (NPPES)License
Gastroenterology PrimaryNJ 25MA06265800
GastroenterologyCT 043843
Internal MedicineCT 043843

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. George Abdelsayed

  • Bayonne University HospitalHospital · Bayonne, NJ
  • Hoboken University HospitalHospital · Hoboken, NJ
  • Robert Wood Johnson University HospitalHospital · New Brunswick, NJ

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. George Abdelsayed's Medicare patients and services (2024)

215Medicare patients
397services billed
71average patient age
48%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more76$137.18
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes48$125.49
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more45$178.18
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes41$81.44
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's32$17
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes28$183.31
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope25$91.46
Biopsy of large bowel using a flexible endoscope24$110.18

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Diabetes59%
  • Chronic kidney disease43%
  • Arthritis43%
  • Ischemic heart disease39%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. George Abdelsayed's Medicare quality score (MIPS 2024)

88.4/100final MIPS score
70.6quality
100promoting interoperability
40improvement activities

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. George Abdelsayed (2025)

$5,416.52 in 18 general payments reported in 2025.

TypePaymentsAmount
Consulting fees1$3,525
Food and beverage16$1,686.77
Travel and lodging1$204.75

Paying companies: Madrigal Pharmaceuticals ($4,683.44), Gilead Sciences, Inc. ($268.78), Mallinckrodt Hospital Products Inc. ($258.10), INTERCEPT PHARMACEUTICALS, INC. ($124.90), GlaxoSmithKline, LLC. ($57.09), Mirum Pharmaceuticals, Inc. ($24.21).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. George Abdelsayed

What kind of clinician is Dr. George Abdelsayed?

Dr. George Abdelsayed is listed as a physician specializing in gastroenterology.

Where does Dr. George Abdelsayed practice?

Rutgers Health-Rwj Scleroderma Program at 125 Paterson St, New Brunswick, NJ 08901, and 1 other address in the records.

What is the office phone number for Dr. George Abdelsayed?

The listed office number is (732) 235-7784. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. George Abdelsayed?

The National Provider Identifier is 1144298613.

Does Dr. George Abdelsayed accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. George Abdelsayed affiliated with?

Bayonne University Hospital, Hoboken University Hospital, Robert Wood Johnson University Hospital.

Where did Dr. George Abdelsayed go to medical school?

New York Medical College, graduating in 1983.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2021-07-23
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare